Filing Details
- Accession Number:
- 0001127602-22-027324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-12 17:08:19
- Reporting Period:
- 2022-12-09
- Accepted Time:
- 2022-12-12 17:08:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1726884 | W Todd Garner | C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773 | Executive Vice President & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-09 | 4,500 | $50.61 | 4,501 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-09 | 4,500 | $89.31 | 1 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options To Purchase Common Stock | Disposition | 2022-12-09 | 4,500 | $0.00 | 4,500 | $50.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
35,100 | 2028-01-02 | No | 4 | M | Direct |
Footnotes
- The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan.
- Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.